The Pharmacogenomics Journal · 2019 · 19 citations · 33 references
MedicinePharmacokineticsPharmacologyMedical GeneticsPharmacogeneticsPharmacogenomicsClinical Implementation Of PharmacogeneticsClinical Implementation Of PharmacogenomicsGenotype-phenotype Association AnalysisCyp2c9 GenotypingGenotype-based Drug DosingGenotype-guided AnticoagulationPharmacogenetic Risk PredictionVkorc1 GenotypeVkorc1 GenotypingWarfarin Pharmacogenetic Testing
33
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
F.R. Rosendaal, Suzanne C. Cannegieter, F.J.M. van der Meer et al. · Thrombosis and Haemostasis · 1993 · 2.1K citations · Full text
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
Simone Rost, Andreas Fregin, Vytautas Ivaškevičius et al. · Nature · 2004 · 1.1K citations
Stuart J. Connolly, Janice Pogue, John W. Eikelboom et al. · Circulation · 2008 · 873 citations · Full text
Medicine, Cardiology, Pharmacology +14